Ha habido 50 transacciones internas recientes registradas para Denali Therapeutics Inc. (DNLI), incluyendo 15 compras y 31 ventas. El total de compras internas fue valorado en $18.74M y el total de ventas internas en $6.73M.
Internos destacados con actividad reciente incluyen Watts Ryan J., Schuth Alexander O., Baker Bros. Advisors Lp. Las transacciones internas pueden proporcionar información sobre cómo la dirección de la empresa ve la valoración y perspectivas futuras de la acción.
Operaciones de Insiders — DNLI
| Fecha |
Nombre |
Cargo |
Tipo de Transacción |
Acciones |
Precio Promedio |
Valor |
Acciones en Propiedad |
| 2026-01-06 |
Watts Ryan J. |
President and CEO |
Venta Informativa |
35,198 |
$16.50 |
$580.77K |
296,833 |
| 2026-01-06 |
Schuth Alexander O. |
Cofo and Secretary |
Venta Informativa |
17,218 |
$16.50 |
$284.1K |
282,828 |
| 2026-01-03 |
Watts Ryan J. |
President and CEO |
Concesión de RSU |
236,880 |
$16.27 |
$3.85M |
236,880 |
| 2026-01-03 |
Schuth Alexander O. |
Cofo and Secretary |
Concesión de RSU |
173,100 |
$16.27 |
$2.82M |
173,100 |
| 2025-12-11 |
Baker Bros. Advisors Lp |
Director |
Compra Informativa |
190,523 |
$0.01 |
$1.91K |
2,335,469 |
| 2025-11-04 |
Van Hauwermeiren Timothy |
Director |
Desconocido |
- |
- |
- |
- |
| 2025-11-04 |
Van Hauwermeiren Timothy |
Director |
Concesión de RSU |
10,632 |
- |
- |
10,632 |
| 2025-09-03 |
Watts Ryan J. |
President and CEO |
Donación (Otorgada) |
50,000 |
- |
- |
2,152,604 |
| 2025-08-13 |
Ho Carole |
Chief Medical Officer |
Venta Informativa |
806 |
$14.64 |
$11.8K |
216,585 |
| 2025-08-12 |
Schuth Alexander O. |
Cofo and Secretary |
Venta Informativa |
2,937 |
$13.58 |
$39.88K |
242,346 |
| 2025-08-12 |
Ho Carole |
Chief Medical Officer |
Venta Informativa |
2,937 |
$13.58 |
$39.88K |
217,391 |
| 2025-08-05 |
Ho Carole |
Chief Medical Officer |
Ejercicio de Opciones (Venta) |
44,655 |
$0.68 |
$30.37K |
62,500 |
| 2025-07-09 |
Watts Ryan J. |
President and CEO |
Ejercicio de Opciones (Venta) |
40,000 |
$5.28 |
$211.2K |
20,369 |
| 2025-06-03 |
Baker Julian |
Officer |
Desconocido |
- |
- |
- |
- |
| 2025-06-03 |
Flatley Jay T |
Director |
Concesión de RSU |
6,037 |
- |
- |
16,220 |
| 2025-06-03 |
Baker Bros. Advisors Lp |
Director |
Desconocido |
23,901,119 |
$0.01 |
$239.01K |
- |
| 2025-06-03 |
Baker Bros. Advisors Lp |
Director |
Concesión de RSU |
31,695 |
$13.93 |
$441.51K |
31,695 |
| 2025-06-03 |
Tessier-lavigne Marc |
Director |
Concesión de RSU |
18,111 |
$13.93 |
$252.29K |
18,111 |
| 2025-06-03 |
Klein Peter S |
Director |
Concesión de RSU |
18,111 |
$13.93 |
$252.29K |
18,111 |
| 2025-06-03 |
Schenkein David P |
Director |
Concesión de RSU |
6,037 |
- |
- |
15,257 |
| 2025-06-03 |
Krognes Steve E. |
Director |
Concesión de RSU |
18,111 |
$13.93 |
$252.29K |
18,111 |
| 2025-06-03 |
Cook Jennifer E. |
Director |
Concesión de RSU |
18,111 |
$13.93 |
$252.29K |
18,111 |
| 2025-06-03 |
Thornberry Nancy |
Director |
Concesión de RSU |
18,111 |
$13.93 |
$252.29K |
18,111 |
| 2025-01-07 |
Krognes Steve E. |
Director |
Venta Informativa |
3,339 |
$20.81 |
$69.48K |
25,757 |
| 2025-01-07 |
Watts Ryan J. |
President and CEO |
Venta Informativa |
7,650 |
$20.81 |
$159.2K |
253,071 |
| 2025-01-07 |
Schuth Alexander O. |
Cofo and Secretary |
Venta Informativa |
2,907 |
$20.81 |
$60.49K |
244,308 |
| 2025-01-07 |
Ho Carole |
Chief Medical Officer |
Venta Informativa |
2,907 |
$20.81 |
$60.49K |
175,673 |
| 2025-01-06 |
Watts Ryan J. |
President and CEO |
Venta Informativa |
29,266 |
$20.22 |
$591.76K |
260,721 |
| 2025-01-06 |
Schuth Alexander O. |
Cofo and Secretary |
Venta Informativa |
12,255 |
$20.22 |
$247.8K |
247,215 |
| 2025-01-06 |
Ho Carole |
Chief Medical Officer |
Venta Informativa |
12,255 |
$20.22 |
$247.8K |
178,580 |
| 2025-01-03 |
Watts Ryan J. |
President and CEO |
Concesión de RSU |
162,540 |
$21.26 |
$3.46M |
162,540 |
| 2025-01-03 |
Schuth Alexander O. |
Cofo and Secretary |
Concesión de RSU |
162,540 |
$21.26 |
$3.46M |
162,540 |
| 2025-01-03 |
Ho Carole |
Chief Medical Officer |
Concesión de RSU |
162,540 |
$21.26 |
$3.46M |
162,540 |
| 2025-01-02 |
Sato Vicki L |
Director |
Venta Informativa |
3,080 |
$20.91 |
$64.4K |
107,976 |
| 2024-12-31 |
Krognes Steve E. |
Director |
Venta Informativa |
30,000 |
$20.25 |
$607.5K |
29,096 |
| 2024-12-27 |
Schuth Alexander O. |
Cofo and Secretary |
Ejercicio de Opciones (Venta) |
6,708 |
$5.28 |
$35.42K |
46,671 |
| 2024-11-25 |
Ho Carole |
Chief Medical Officer |
Ejercicio de Opciones (Venta) |
17,845 |
$0.68 |
$12.13K |
107,155 |
| 2024-11-22 |
Schuth Alexander O. |
Cofo and Secretary |
Ejercicio de Opciones (Venta) |
20,516 |
$0.68 |
$13.95K |
124,562 |
| 2024-11-11 |
Schenkein David P |
Director |
Ejercicio de Opciones (Venta) |
47,165 |
$18.00 |
$848.97K |
- |
| 2024-11-07 |
Sato Vicki L |
Director |
Venta Informativa |
1,020 |
$30.00 |
$30.6K |
111,056 |
| 2024-11-07 |
Schuth Alexander O. |
Cofo and Secretary |
Ejercicio de Opciones (Venta) |
15,558 |
$5.28 |
$82.15K |
53,379 |
| 2024-11-01 |
Sato Vicki L |
Director |
Venta Informativa |
3,080 |
$27.07 |
$83.38K |
112,076 |
| 2024-10-18 |
Watts Ryan J. |
President and CEO |
Venta Informativa |
40,000 |
$27.69 |
$1.11M |
235,807 |
| 2024-09-30 |
Krognes Steve E. |
Director |
Venta Informativa |
30,000 |
$29.03 |
$870.9K |
29,096 |
| 2024-09-13 |
Sato Vicki L |
Director |
Venta Informativa |
1,020 |
$30.00 |
$30.6K |
115,156 |
| 2024-09-03 |
Sato Vicki L |
Director |
Venta Informativa |
100 |
$25.37 |
$2.54K |
116,176 |
| 2024-08-21 |
Schuth Alexander O. |
Cofo and Secretary |
Venta Informativa |
2,547 |
$24.78 |
$63.11K |
178,066 |
| 2024-08-21 |
Ho Carole |
Chief Medical Officer |
Venta Informativa |
5,907 |
$24.96 |
$147.44K |
118,810 |
| 2024-08-20 |
Krognes Steve E. |
Director |
Venta Informativa |
1,727 |
$23.79 |
$41.09K |
32,677 |
| 2024-08-20 |
Watts Ryan J. |
President and CEO |
Venta Informativa |
2,260 |
$23.79 |
$53.77K |
235,807 |
■ Informativa — transacción en mercado abierto (más significativa)
■ No informativa (compra) — premio, ejercicio de opción, conversión
■ No informativa (venta) — retención fiscal, venta de adjudicación
■ Neutral — regalo, fideicomiso, vencimiento
